Introduction: Tuberculosis is an infectious disease that mainly affects the lung. Extrapulmonary localizations are a reason for hospitalization in our health facilities. The objective of this study was to describe the epidemiological, clinical, paraclinical and evolutionary aspects of extra pulmonary tuberculosis (EPT) at the Abass Ndao Hospital Center. Patients and Methods: This was a descriptive cross-sectional study conducted over a period of 11 years (January 1, 2010 to December 30, 2021). All patients with extrapulmonary tuberculosis hospitalized in the department of internal medicine during the recruitment period were included. Results: Fifty-two (52) patients were collected. The year 2019 recorded the most cases 23.08% (n = 20). The mean age of the patients was 40.56 ± 18.24 years. The age group 20 - 34 years 42.31% (n = 22) was the most represented. Females were in the majority 61.54% (n = 32) with a sex ratio (M/F) was 0.63. Housewives were in the majority 40.38% (n = 21). 60.87% of the cases (n = 14) came from a health facility. 38.46% of the cases had been infected. 21.74% (n = 9) were smokers. The reasons for consultation were dominated by fever (67.44%), AEG (62.79%) and cough (41.86%). Eighteen patients (40.91%) had fever. The mean time to consultation was 77.37 ± 90.3 days with extremes of 3 and 365 days. The median was 45 days. More than half of the patients 61.90% (n = 26) had anemia. Positive retroviral serology was noted in 21.43% of cases. All patients had a CRP greater than 6. More than half of the patients 51.92% (n = 27) had multifocal tuberculosis. The peritoneum 44.23% (n = 23) was the main organ affected. The average hospital stay was 9.8 ± 4.9 days with extremes of 1 and 19 days. All patients had received the protocol in force at the national level. Death was noted in 4 patients (9.52%). Conclusion: EPT is characterized in our context by a notorious diagnostic difficulty due to the multiplicity of clinical presentations, the complexity of explorations, and the problems of differential diagnosis notably with other granulomatosis, systemic lupus and cancers. This difficulty is reflected in the low rate of diagnosis with a paraclinical argument of certainty and in the long diagnostic delays.
References
[1]
Mjid, M., Cherif, J., Ben Salah, N., Toujani, S., Ouahchi, Y., Zakhama, H., et al. (2015) Epidémiologie de la tuberculose. Revue de Pneumologie Clinique, 71, 67-72. https://doi.org/10.1016/j.pneumo.2014.04.002
[2]
Charles, H., Christel, J. and Fadiler, D. (2002) Histoire de la tuberculose. Annals of Internal Medicine, 153, 97-106.
[3]
Harries, A., Maher, D., et al. (1986) Tuberculose et VIH, Manuel Clinique. Edition OMS.
[4]
Prévalence des cas de Tuberculose en 2020 (2020) Direction de la Plannification, de la recherche et des statistiques au Senegal, Bulletin N 46.
[5]
Djibril Sow, K., Yanogo, P., Ndiaye, M., et al. (2021) 48 - Profil épidémiologique de la tuberculose, Sénégal, 2009-2018. Revue d’épidémiologie et de Santé Publique, 70, S161-S162. https://doi.org/10.1016/j.respe.2022.06.093
Nganda, C.K., Muteya, M.M., Lukusha, Y.I.I., et al. (2014) Profil épidémiologique et clinique de la tuberculose dans la zone de santé de Lubumbashi (RD Congo). Pan African Medical Journal, 17, Article 70. https://doi.org/10.11604/pamj.2014.17.70.2445
[8]
Diop, M.M., Touré, K., Bousso, S., et al. (2017) Prévalence et Formes cliniques de la tuberculose extrapulmonaire dans le district sanitaire de Thiès. Revue Africaine de Médecine Interne, 4, 6-9
[9]
Organisation mondiale de la santé définition des cadres de notification pour la tuberculose révision 2013. https://www.who.int/fr/publications-detail/9789241505345
[10]
Guillet-Caruba, C., Martinez, V. and Doucet-Populaire, F. (2014) Les nouveaux outils de diagnostic microbiologique de la tuberculose maladie. La Revue de Médecine Interne, 35, 794-800. https://doi.org/10.1016/j.revmed.2014.05.001
[11]
Mazza-Stalder, M., Nicod, L. and Janssens, J.-P. (2012) La tuberculose extrapulmonaire. Revue des Maladies Respiratoires, 29, 566-578. https://doi.org/10.1016/j.rmr.2011.05.021
[12]
Faye, A., Djiba, B., Kane, B.S., et al. (2020) The Extrapulmonary Tuberculosis in an Internal Medicine Department in Tropical Areas. RAFMI, 7, 20-25.
[13]
Abid, R., Hannachi, S., Arfaoui, B. and Battikh, R. (2020) Tuberculose Extra Pulmonaire: Toujours et encore. Médecine et maladies infectieuses, 50, S31-S199. https://doi.org/10.1016/j.medmal.2020.06.324
[14]
Ponce-De-Leon, A., de Lourdes Garcia-Garcia, M., Garcia-Sancho, M.C., et al. (2004) Tuberculosis and Diabetes in Southern Mexico. Diabetes Care, 27, 1584-1590. https://doi.org/10.2337/diacare.27.7.1584
[15]
Alisjahbana, B., van Crevel, R., Sahiratmadja, E., et al. (2006) Diabetes Mellitus Is Strongly Associated with Tuberculosis in Indonesia. International Journal of Tuberculosis & Lung Disease, 10, 696-700.
[16]
Slim-Saidi, L., Mehiri-Zeghal, E., Ghariani, A. and Tritar, F. (2015) Nouvelles méthodes de diagnostic de la tuberculose. Revue de Pneumologie Clinique, 71, 110-121. https://doi.org/10.1016/j.pneumo.2015.02.002
[17]
Minion, J., Madhukar, P., Ramsay, A., Menzies, D. and Greenaway, C. (2011) Comparison of LED and Conventional Fluorescent Microscopy for Detection of Acid Fast Bacilli in a Low Incidence Setting. PLOS ONE, 6, e22495. https://doi.org/10.1371/journal.pone.0022495
[18]
Grosset, J. (1995) Place des examens microbiologiques et anatomopathologiques dans la décision diagnostique et thérapeutique. Médecine et Maladies Infectieuses, 25, 327-333. https://doi.org/10.1016/S0399-077X(05)80591-8
[19]
Boehme, C., Nicol, M.P., Nabeta, P., Michael, J.S., et al. (2011) Feasibility, Diagnostic Accuracy and Effectiveness of Decentralised Use of the Xpert MTB/RIF Test for Diagnosis of Tuberculosis and Multidrug Resistance: A Multicenter Implementation Study. Lancet, 377, 1495-1505. https://doi.org/10.1016/S0140-6736(11)60438-8
[20]
Hillemann, D., Rusch-Gerdes, S., Boehme, C. and Richter, E. (2011) Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System. Journal of Clinical Microbiology, 49, 1202-1204. https://doi.org/10.1128/JCM.02268-10
[21]
Jabri, H., Lakhdar, N., El Khattabi, W. and Afif, H. (2016) Les moyens diagnostiques de la tuberculose. Revue de Pneumologie Clinique, 72, 320-325. https://doi.org/10.1016/j.pneumo.2016.06.003
[22]
Diel, R., Goletti, D., Ferrara, G., Bothamley, G., et al. (2011) Interferon Release Assays for the Diagnosis of Latent Mycobacterium Tuberculosis Infection: A Systematic Review and Meta-Analysis. The European Respiratory Journal, 37, 88-99. https://doi.org/10.1183/09031936.00115110
[23]
Mori, T., Sakatani, M., Yamagishi, F., Takashima, T., Kawabe, Y., Nagao, K., et al. (2004) Specific Detection of Tuberculosis Infection: An Interferon Based Assay Using New Antigens. American Journal of Respiratory and Critical Care Medicine, 170, 59-64. https://doi.org/10.1164/rccm.200402-179OC
